In the past decade clinical and laboratory studies have led to important new insights into the
biology of chronic myeloid leukemia (CML). Basic science has defined the molecular …

An extraordinary series of discoveries about chronic myeloid leukemia (CML) has made this
disease a model of the way in which bench and bedside research can unite and culminate …

Chronic myeloid leukemia (CML) is a clonal myeloproliferative expansion of transformed,
primitive hematopoietic progenitor cells. It involves myeloid, monocytic, erythroid …

Craigie, 3 Bennett, 4 and Virchow,#{176} who noted the classic features of “purulence” of the
blood and marked splenomegaly. CML was the first human neoplasm to be associated with …

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder that follows a
characteristic clinical course in which a chronic phase of variable duration precedes an …

In the last decade, improvements in both non-transplant and transplant therapy have
extended the lives of patients with CML, particularly those in chronic phase. The future will …

The progress made in the understanding of chronic myeloid leukemia (CML) since the
recognition of a common chromosomal abnormality to the introduction of ever more effective …

Chronic myelogenous leukemia classically progresses through 3 phases, becoming more
resistant to treatment in each successive phase. The majority of patients present in the …

Chronic myeloid leukemia (CML) is one of the most common leukemias occurring in the
adult population. The course of CML is divided into three phases: the chronic phase, the …

Chronic Myeloid Leukaemia (CML) is a clonal, myeloproliferative disease that develops
when a single, pluripotential, haemopoetic stem cell acquires the Philadelphia chromosome …